- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 14.05. | Fractyl Health Partners with Forge for Rejuva Gene Therapy Development | ||
| 14.05. | GSK to Acquire Boston Pharma's Promising Liver Disease Drug | ||
| 14.05. | Ecolab Opens New U.S. Bioprocessing Applications Lab in PA | ||
| 13.05. | Segmed Appoints David Gasoigne as CEO | ||
| 13.05. | Thermo Fisher Scientific Introduces Automated Plasmid DNA Purification Kit | ||
| 13.05. | Recipharm, PLG Partner to Accelerate Development Projects | ||
| 13.05. | Bora Pharmaceuticals Appoints JB Agnus as CCO | ||
| 13.05. | Hansa Biopharma Taps Maria Törnsén as COO and President U.S. | ||
| 13.05. | eXmoor Pharma, KU Leuven Partner to Support New Cell & Gene Therapy Hub | ||
| 13.05. | Rockwell Automation Introduces FactoryTalk PharmaSuite 12.00 | ||
| 13.05. | Stylus Medicine Emerges from Stealth | ||
| 12.05. | Ratio Therapeutics to Build a Radiopharmaceutical Manufacturing Facility in Utah | ||
| 12.05. | Piramal Pharma to Expand Two U.S. Sites | ||
| 12.05. | Andelyn Manufactures Novel Gene Therapy for Ultra-Rare NEDAMSS Disease Patient | ||
| 12.05. | Aera Therapeutics Appoints Paul Conrad Chief Business and Financial Officer | ||
| 12.05. | Peter Soelkner Steps Down as Managing Director at Vetter | ||
| 12.05. | Genentech & Roche Announce New Drug Manufacturing Facility in Holly Springs, NC | ||
| 09.05. | Univercells Launches Scale-X Nitro Controller | ||
| 09.05. | Think Bioscience & CrystalsFirst to Expand Partnership | ||
| 09.05. | Lilly to Expand Purdue University Alliance with $250M Investment | ||
| 08.05. | Takeda to Invest $30B into U.S. Operations | ||
| 08.05. | Schreiner MediPharm Introduces Digital Display Label | ||
| 08.05. | NewBiologix Licenses Xcell-Eng-HEK293 Cell Line to ReciBioPharm | ||
| 08.05. | Gilead Sciences Increases Investment in U.S. Operations | ||
| 08.05. | ACG Packaging Materials' GHG Emission Reduction Targets Validated by SBTi |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .